BioSpace News Archive

McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its UK businesses to AURELIUS

Kaleido Biosciences, Inc. today reported financial results for the third quarter ended September 30, 2021.

Graybug Vision, Inc. announced two clinical data presentations at the American Academy of Ophthalmology 2021 Annual Meeting to be held on November 12-15, 2021 in New Orleans, Louisiana, as well as a company presentation at the Eyecelerator@AAO 2021 event on November 11, 2021:

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held on Thursday, November 4, 2021 at 8:30 AM ET to discuss results for the third quarter 2021 and provide a business outlook for the Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title

Coherus BioSciences, Inc. announced today that the United States Food and Drug Administration (“FDA”) has accepted for review the Biologics License Application (“BLA”) for toripalimab in combination with gemcitabine and cisplatin for the first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma (“NPC”)

Mind Medicine (MindMed) Inc. is pleased to announce that CEO Robert Barrow will be speaking at Web Summit, taking place on November 1-4, 2021 in Lisbon, Portugal .

Soligenix, Inc. announced today that Oreola Donini, PhD, Chief Scientific Officer, will be presenting key data from the Company’s thermostable vaccine technology platform, including results from the Company’s programs for ricin toxin vaccine (RiVax®), COVID-19 vaccine (CiVax™) and filovirus vaccines (targeting Ebola, Sudan, and Marburg viruses).

OrbiMed is pleased to announce two new team additions who are among the global biotechnology industry’s most talented and capable professionals.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) – November 12-15, 2021

Arch Therapeutics, Inc. (OTCQB: ARTH) (“ Arch ” or the “ Company ”), a marketer and developer of novel self-assembling wound care and biosurgical devices, presented at the Symposium on Advanced Wound Care (SAWC) during the “Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care” session on October 31, 2021.